Updated Views on Ducera 2026
how has Ducera been looking as of recent as far as deal flow? any insight into how they've been performing or anything about the firm would be awesome
how has Ducera been looking as of recent as far as deal flow? any insight into how they've been performing or anything about the firm would be awesome
| +278 | Return Rates For Interns Are Falling? | 113 | 1m |
| +123 | Article: Why UBS's Asian M&A bankers are thriving and UBS's American M&A bankers are not | 13 | 1h |
| +114 | I am a drunk MD AMA | 39 | 1d |
| +73 | UBS Offer Day | 27 | 3h |
| +64 | VP Lifestyle at Top BB Coverage Groups | 40 | 2d |
| +57 | An Outsider’s View of RX Banking Out of College | 6 | 5d |
| +46 | No return so what are the options left | 31 | 4h |
| +45 | Evercore > Goldman and I don’t think it’s particularly close anymore | 21 | 6m |
| +41 | WF Return offers | 28 | 2h |
| +41 | I hate Wells Fargo | 7 | 51m |
Career Resources
Based on the most helpful WSO content, Ducera Partners has historically been recognized as a strong player in the restructuring (RX) space, often punching above its weight in RX mandates. However, there have been discussions suggesting a shift towards a more generalist focus due to a slowdown in RX deal flow. This could indicate a strategic pivot to diversify their offerings, including M&A and strategic advisory work.
In terms of M&A, the firm appears to focus more on middle-market transactions, as their reputation in M&A may not yet match their RX expertise. Despite this, they are noted for having sharp professionals and a rigorous interview process, which suggests a high standard for talent.
Compensation has been a topic of interest, with some speculation about whether they have adjusted salaries to align with market trends (e.g., $95k/$110k for analysts). However, no concrete updates on this have been provided in the recent threads.
If you're looking for insights into their culture, it's described as intense, with younger professionals working hard but gaining exposure to high-caliber deals. Exit opportunities might be somewhat influenced by the firm's RX-heavy background, but their evolving focus could open doors in other areas as well.
For the most accurate and up-to-date information, it might be worth checking recent discussions or reaching out to current employees.
Sources: Ducera 2022 Info?, Ducera vs. M. Klein?, New Info on Ducera Partners - RX Shop, https://www.wallstreetoasis.com/forum/investment-banking/ducera-partners-2020-info?customgpt=1, Ducera Partners is an Elite Boutique now - which existing EB gets kicked out of its spot?
Bump
Would not join their strategic advisory group
Fuga quis eos nisi sint illum dolore sed. Vel maiores et facilis sint sed sint. Sed quasi ut pariatur fugiat. Ut sequi adipisci autem enim ut sapiente molestiae. In voluptatem doloribus in saepe sed. Omnis omnis illum et velit. Tempora mollitia sapiente voluptate qui eos sint provident.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...